# Johns Hopkins Study Reveals Cannabis Mental Health Risks > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/johns-hopkins-cannabis-mental-health-risks/ > **Published:** 2026-04-14T15:23:04-04:00 | **Last Modified / Clinically Audited:** 2026-09-29T00:21:23-04:00 > **Clinical Summary:** Explore Johns Hopkins cannabis mental health risks study highlighting psychiatric vulnerabilities linked to recreational cannabis use in Maryland. --- ✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. Mental HealthResearchSafetyPolicy Clinical Summary # Clinical Summary A Johns Hopkins University study examining [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) patterns in Maryland identified heightened mental health risks associated with recreational [cannabis legalization](https://cedclinic.com/the-forgotten-history-of-hemp-in-america/) in certain populations. The research was initiated following Maryland’s legalization of recreational cannabis and built upon previous epidemiological evidence linking cannabis exposure to psychiatric complications. The study appears to highlight vulnerable subgroups who may experience disproportionate mental health consequences from increased cannabis availability and use, though the specific risk factors and populations require clarification from the full publication. These findings are clinically relevant as they inform risk stratification for patients in states with legal cannabis markets, where clinicians must counsel patients on individualized psychiatric vulnerability. Physicians should consider detailed mental health screening and personal or family psychiatric history when discussing cannabis use with patients in legalized jurisdictions, particularly for those with predisposing risk factors for psychotic or mood disorders. Dr. Caplan’s Take “What we’re seeing in the literature is that cannabis isn’t the monolithic substance people debate in policy circles—the mental health risks vary significantly based on individual vulnerability factors, age of initiation, and product potency, which means my clinical responsibility is to screen for these factors before recommending or endorsing use, not to make blanket statements either way.” Clinical Perspective Recent evidence from Johns Hopkins suggests that cannabis use carries meaningful mental health risks, particularly in certain populations, findings that merit clinical attention as legalization expands across jurisdictions. However, clinicians should recognize that observational studies identifying associations between [cannabis and psychiatric outcomes](https://cedclinic.com/cannabis-psychosis-study-colorado/) cannot definitively establish causality, and confounding factors such as underlying mental health vulnerabilities, concurrent substance use, and sociodemographic stressors complicate interpretation. The variable potency of modern cannabis products, frequency of use patterns, and individual differences in [cannabinoid metabolism](https://cedclinic.com/fatty-acid-amide-hydrolase-obesity-risk-genetic-links/) further introduce heterogeneity that limits generalization to all patients. Given these complexities, the practical implication for primary care and mental health providers is to routinely screen patients about cannabis use—particularly those with personal or family histories of psychiatric illness—and to counsel patients that legalization does not eliminate potential risks, especially regarding psychotic symptoms, cognitive effects, and depressive outcomes in susceptible individuals. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/mental-health/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Johns+Hopkins+Study+Finds+Cannabis+Use+May+Pose+Greater+Mental+Health+Risks+in+...+%40drcaplan&url=https%3A%2F%2Fmedicalresearch.com%2Fjohns-hopkins-study-finds-cannabis-use-may-pose-greater-mental-health-risks-in-adolescents-than-adults%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fmedicalresearch.com%2Fjohns-hopkins-study-finds-cannabis-use-may-pose-greater-mental-health-risks-in-adolescents-than-adults%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Johns+Hopkins+Study+Finds+Cannabis+Use+May+Pose+Greater+Mental+Health+Risks+in+...+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fmedicalresearch.com%2Fjohns-hopkins-study-finds-cannabis-use-may-pose-greater-mental-health-risks-in-adolescents-than-adults%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [New Research Reveals Age Plays Key Role in Cannabis‑Related Psychiatric Risks](https://cedclinic.com/cannabis-related-psychiatric-risks-adolescents/) 📰 Source: [https://medicalresearch.com/johns-hopkins-study-finds-cannabis-use-may-pose-greater-mental-health-risks-in-adolescents-than-adults/](https://medicalresearch.com/johns-hopkins-study-finds-cannabis-use-may-pose-greater-mental-health-risks-in-adolescents-than-adults/) Further Reading CED Clinic Blog[Medical Cannabis Counseling for Older Adults: What Physicians Are Telling Patients](https://cedclinic.com/medical-cannabis-counseling-older-adults-guidance/) Research Digest[Research Digest: 4 Recent Studies – April 09, 2026](https://cedclinic.com/4-recent-cannabis-research-studies-april-2026/) Evidence WatchMetformin reverses oxandrolone-induced anxiety-like behavior and amygdalar neurochemical dysregulation in male rats. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Study identifies genetic pathways linking cannabis use and psychosis – News-Medical.Net](https://cedclinic.com/researchers-identify-genetic-pathways-linking-cannabis-use-disorder-and-psychosis-risk/) Explore genetic factors connecting cannabis use with psychosis risk, providing deeper insight into mental health implications. [Read More](https://cedclinic.com/researchers-identify-genetic-pathways-linking-cannabis-use-disorder-and-psychosis-risk/) [Endocannabinoid System Research: Teen Cannabis & Mental Health](https://cedclinic.com/endocannabinoid-system-adolescent-psychiatric-risk/) Discover research on how teen cannabis use affects the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) and mental health outcomes. [Learn More](https://cedclinic.com/endocannabinoid-system-adolescent-psychiatric-risk/) [High-potency cannabis linked to mental health risks, expert warns](https://cedclinic.com/high-potency-cannabis-linked-to-mental-health-risks-expert-warns/) An expert analysis on the increased mental health risks associated with high-potency cannabis products. [Explore Insights](https://cedclinic.com/high-potency-cannabis-linked-to-mental-health-risks-expert-warns/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).